Thromb Haemost 1985; 54(02): 557
DOI: 10.1055/s-0038-1657904
Letter to the Editor
Schattauer GmbH Stuttgart

Thrombocytopenia Related to Synthetic Heparin Analogue Therapy

M Gouault-Heilmann
Hôpital Henri Mondor, Créteil, France
,
D Payen
Hôpital Henri Mondor, Créteil, France
,
G Contant
Hôpital Henri Mondor, Créteil, France
,
L Intrator
Hôpital Henri Mondor, Créteil, France
,
Y Huet
Hôpital Henri Mondor, Créteil, France
,
A Schaeffer
Hôpital Henri Mondor, Créteil, France
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received 11. Februar 1985

Accepted 22. Mai 1985

Publikationsdatum:
18. Juli 2018 (online)

 
  • References

  • 1 Huisse MG, Guillin CC, Bezeaud A, Toulemonde F, Kitzis M. Heparin-associated thrombocytopenia. In vitro effects of different molecular weight heparin fractions. Thromb Res 1982; 27: 485-490
  • 2 Roussi JH, Houbouyan LL, Goguel AF. Use of low-molecular weight in heparin-induced thrombocytopenia with thrombotic complications. Lancet 1984; 2: 1183
  • 3 Harenberg H, Zimmermann R, Schwarz F, Kubler W. Treatment of heparin-induced thrombocytopenia with thrombosis by new heparinoid. Lancet 1983; 2: 986-987
  • 4 Horellou MH, Conard J, Lecrubier C, Samama M, Roque-D'Obercastel O, De Fenoyl O, Dimaria G, Bernadou A. Persistent heparin-induced thrombocytopenia despite therapy with low molecular weight heparin. Thromb Haemostas 1984; 51: 134